Year archive

MESOBLAST LTD — 2017 filings

All 123 regulatory filings released by MESOBLAST LTD (MESO) in 2017, sourced directly from the official regulator.

123 Filings

2017 Period

2017 filings (123)

Filing	Released	Lang
6-K Foreign Filer Report	2017-12-22	English
Change of Director's Interest Notice 2 pages 95.3KB Regulatory Filings	2017-12-21	English
6-K Foreign Filer Report	2017-12-21	English
Mesoblast Receives RMAT For LVAD Heart Failure Patients 3 pages 93.7KB Regulatory Filings	2017-12-20	English
Mesoblast's P3 GVHD Trial Completes Enrollment 2 pages 98.6KB Regulatory Filings	2017-12-19	English
Release of shares from voluntary escrow 1 page 88.0 Regulatory Filings	2017-12-19	English
6-K Foreign Filer Report	2017-12-18	English
Mesoblast Grants TiGenix License For Treatment of Fistulae 3 pages 80.7KB Regulatory Filings	2017-12-14	English
6-K Foreign Filer Report	2017-12-11	English
MSB Named Global Technology Leader In Cell Therapy Industry 2 pages 95.7KB Regulatory Filings	2017-12-07	English
Change in substantial holding 5 pages 267.9KB Regulatory Filings	2017-12-06	English
Change in substantial holding 5 pages 275.5KB Regulatory Filings	2017-12-04	English
Response to ASX Aware Letter Query 7 pages 522.5KB Regulatory Filings	2017-11-16	English
6-K Foreign Filer Report	2017-11-16	English
6-K Foreign Filer Report	2017-11-16	English
6-K Foreign Filer Report	2017-11-16	English
Chairman's Address to Shareholders 2 pages 98.8KB Regulatory Filings	2017-11-15	English
CEO Presentation to 2017 Annual General Meeting 43 pages 3.9MB Regulatory Filings	2017-11-15	English
Results of Meeting 2 pages 172.4KB Regulatory Filings	2017-11-15	English
First Quarter Results On Form 6K 71 pages 385.4KB Regulatory Filings	2017-11-14	English
First Quarter Results Presentation 45 pages 3.9MB Regulatory Filings	2017-11-14	English
Mesoblast Provides Corporate Update and Q1 Financial Results 8 pages 207.0KB Regulatory Filings	2017-11-14	English
Ceasing to be a substantial holder 14 pages 2.7MB Regulatory Filings	2017-11-14	English
RA Phase 2 Trial Results Presented At ACR Annual Meeting 5 pages 140.4KB Regulatory Filings	2017-11-12	English
Becoming a substantial holder 52 pages 6.6MB Regulatory Filings	2017-11-12	English
Mesoblast Presents At Credit Suisse Healthcare Conference 2 pages 76.7KB Regulatory Filings	2017-11-08	English
6-K Foreign Filer Report	2017-11-01	English
Appendix 4C - quarterly 6 pages 117.7KB Regulatory Filings	2017-10-30	English
Ceasing to be a substantial holder 28 pages 1.1MB Regulatory Filings	2017-10-29	English
Becoming a substantial holder 53 pages 4.2MB Regulatory Filings	2017-10-26	English
Ceasing to be a substantial holder 2 pages 121.9KB Regulatory Filings	2017-10-26	English
6-K Foreign Filer Report	2017-10-18	English
S-8 Registration Form	2017-10-17	English
Appendix 4G and Corporate Governance Statement 20 pages 182.3KB Regulatory Filings	2017-10-15	English
Notice of Annual General Meeting/Proxy Form 14 pages 300.3KB Regulatory Filings	2017-10-15	English
Annual Report to shareholders 214 pages 3.0MB Regulatory Filings	2017-10-15	English
6-K Foreign Filer Report	2017-10-10	English
Appendix 3B 6 pages 81.6KB Regulatory Filings	2017-10-05	English
6-K Foreign Filer Report	2017-10-02	English
6-K Foreign Filer Report	2017-09-28	English
End-Stage Heart Failure Trial Completes Enrollment 3 pages 126.2KB Regulatory Filings	2017-09-27	English
Change of Director's Interest Notices 10 pages 238.3KB Regulatory Filings	2017-09-24	English
Mesoblast Corporate Updates at Healthcare Conferences 2 pages 96.4KB Regulatory Filings	2017-09-24	English
6-K Foreign Filer Report	2017-09-19	English
Appendix 3B 9 pages 142.6KB Regulatory Filings	2017-09-17	English
Mesoblast Completes A$50.7 Million Raise 2 pages 92.2KB Regulatory Filings	2017-09-14	English
6-K Foreign Filer Report	2017-09-07	English
Change in substantial holding 5 pages 86.4KB Regulatory Filings	2017-09-05	English
Change of Director Interest and Substantial Holding Notices 5 pages 335.3KB Regulatory Filings	2017-09-05	English
6-K Foreign Filer Report	2017-09-01	English
Retail Entitlement Offer 26 pages 702.5KB Regulatory Filings	2017-08-31	English
20-F 30 JUNE 2017 Annual Report FY 2017	2017-08-30	English
6-K Foreign Filer Report	2017-08-30	English
Preliminary Final Report including Appendix 4E 217 pages 1.5MB Regulatory Filings	2017-08-29	English
Annual Financial Results Presentation 33 pages 3.4MB Regulatory Filings	2017-08-29	English
Mesoblast Reports on Annual and Fourth Quarter Results 12 pages 268.2KB Regulatory Filings	2017-08-29	English
Underwritten A$50.7M Raise Closes Institutional Allocation 2 pages 94.9KB Regulatory Filings	2017-08-28	English
Trading Halt 2 pages 342.2KB Regulatory Filings	2017-08-24	English
Fully Underwritten A$50.7 Million Entitlement Offer 4 pages 182.1KB Regulatory Filings	2017-08-24	English
Fully Underwritten Entitlement Offer Presentation 58 pages 3.9MB Regulatory Filings	2017-08-24	English
Appendix 3B 9 pages 144.7KB Regulatory Filings	2017-08-24	English
Cleansing notice 1 page 148.0KB Regulatory Filings	2017-08-24	English
Potential For Accelerated Market Entry In Advanced CHF 3 pages 100.2KB Regulatory Filings	2017-08-22	English
6-K Foreign Filer Report	2017-08-18	English
Positive Results of MSB Therapy in Osteoarthritis Published 3 pages 121.3KB Regulatory Filings	2017-08-15	English
Release of shares from voluntary escrow 1 page 88.1 Regulatory Filings	2017-08-07	English
6-K Foreign Filer Report	2017-08-03	English
Appendix 4C - quarterly 6 pages 100.3KB Regulatory Filings	2017-07-30	English
Regulatory Filings 2017 Regulatory Filings	2017-07-24	English
Regulatory Filings 2017 Regulatory Filings	2017-07-20	English
Regulatory Filings 2017 Regulatory Filings	2017-07-19	English
6-K Foreign Filer Report	2017-07-17	English
Change in substantial holding 5 pages 266.6KB Regulatory Filings	2017-07-12	English
FORM F-3 Regulatory Filings	2017-07-10	English
Cleansing notice and Appendix 3B 10 pages 240.5KB Regulatory Filings	2017-07-09	English
6-K Foreign Filer Report	2017-06-27	English
Mesoblast RA Results Presented At EULAR Congress 2 pages 78.2KB Regulatory Filings	2017-06-21	English
MESO-Q3FY17-31MAR2017 Foreign Filer Report	2017-05-25	English
Third Quarter Financial Results On Form 6-K 125 pages 4.1MB Regulatory Filings	2017-05-24	English
Third Quarter Results Presentation 34 pages 3.1MB Regulatory Filings	2017-05-24	English
MSB Provides Q3 Operational Highlights and Financial Results 9 pages 246.4KB Regulatory Filings	2017-05-24	English
6-K Foreign Filer Report	2017-05-05	English
6-K Foreign Filer Report	2017-05-03	English
Change of Director's Interest Notice 3 pages 94.5KB Regulatory Filings	2017-05-01	English
Appendix 4C - quarterly 6 pages 101.5KB Regulatory Filings	2017-04-27	English
Change in substantial holding 10 pages 405.7KB Regulatory Filings	2017-04-23	English
6-K Foreign Filer Report	2017-04-13	English
Successful Interim Analysis in Phase 3 Heart Failure Trial 3 pages 374.8KB Regulatory Filings	2017-04-09	English
6-K Foreign Filer Report	2017-04-07	English
Mesoblast Receives A$3.7m From Aus Govt For R&D 1 p Regulatory Filings	2017-04-05	English
FDA Clears Heart Disease Trial At Boston Childrens Hospital 2 pages 99.0KB Regulatory Filings	2017-04-03	English
6-K Foreign Filer Report	2017-04-03	English
Change in substantial holding 6 pages 285.7KB Regulatory Filings	2017-04-02	English
6-K Foreign Filer Report	2017-03-31	English
Process Initiated For CHF P3 Interim Analysis 2 pages 97.7KB Regulatory Filings	2017-03-30	English
Cleansing notice and Appendix 3B 9 pages 240.7KB Regulatory Filings	2017-03-30	English
Becoming a substantial holder from TEK 4 pages 111.8KB Regulatory Filings	2017-03-30	English
Mesoblast Raises US$40 Million 2 pages 95.8KB Regulatory Filings	2017-03-26	English
6-K Foreign Filer Report	2017-03-20	English
Durable Three Year Outcomes in Disc Disease 3 pages 110.4KB Regulatory Filings	2017-03-14	English
6-K Foreign Filer Report	2017-03-08	English
FDA Grants Mesoblast Fast Track Designation For GVHD 2 pages 97.7KB Regulatory Filings	2017-03-06	English
MESO-Q2FY17-31DEC2016 Foreign Filer Report	2017-02-28	English
Half Year Report and Accounts (including Appendix 4D) 133 pages 4.1MB Regulatory Filings	2017-02-26	English
Half Year Results Presentation 35 pages 2.8MB Regulatory Filings	2017-02-26	English
Mesoblast Provides Half Year Results And Corporate Update 9 pages 226.3KB Regulatory Filings	2017-02-26	English
6-K Foreign Filer Report	2017-02-17	English
Positive Nine Month RA Results For Mesoblast Cell Therapy 6 pages 190.8KB Regulatory Filings	2017-02-15	English
Presentation On Mesoblast RA P2 9 Month Trial Results 24 pages 2.6MB Regulatory Filings	2017-02-15	English
SC 13G Major Shareholding Notification	2017-02-14	English
MESOBLAST LIMITED Major Shareholding Notification	2017-02-14	English
SC 13G/A Major Shareholding Notification	2017-02-13	English
Published Results Show MSB Cells Effective In RA Model 2 pages 122.1KB Regulatory Filings	2017-02-12	English
Release of shares from voluntary escrow 1 page 88.2 Regulatory Filings	2017-02-09	English
6-K APPENDIX 4C Foreign Filer Report	2017-02-03	English
Mesoblast Director Recognized For Cardiovascular Leadership 2 pages 96.4KB Regulatory Filings	2017-01-30	English
Appendix 4C - quarterly 6 pages 63.6KB Regulatory Filings	2017-01-30	English
6-K JPM PRESENTATION Foreign Filer Report	2017-01-17	English
MSB Presentation To Annual J.P.Morgan Healthcare Conference 38 pages 3.9MB Regulatory Filings	2017-01-12	English
6-K - JP MORGAN PRESENTATION Foreign Filer Report	2017-01-12	English
6-K MALLINCKRODT SHARE ISSUE Foreign Filer Report	2017-01-12	English
Presentation at JP Morgan Healthcare Conference 1 p Regulatory Filings	2017-01-10	English
MSB Receives A$29.6Million, Appendix 3B Share Issue 10 pages 244.4KB Regulatory Filings	2017-01-08	English

Filings by year

2026 64 filings
2025 202 filings
2024 141 filings
2023 127 filings
2022 135 filings
2021 101 filings
2020 152 filings
2019 117 filings
2018 107 filings
2017 123 filings
2016 97 filings
2015 92 filings
2014 55 filings
2013 53 filings
2012 34 filings
2011 60 filings
2010 63 filings
2009 56 filings
2008 55 filings
2007 48 filings
2006 62 filings
2005 55 filings
2004 14 filings